[HTML][HTML] Brain neurotransmitter modulation by gut microbiota in anxiety and depression
F Huang, X Wu - Frontiers in cell and developmental biology, 2021 - frontiersin.org
Anxiety and depression are highly prevalent mental illnesses worldwide and have long
been thought to be closely associated to neurotransmitter modulation. There is growing …
been thought to be closely associated to neurotransmitter modulation. There is growing …
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
JC Felger, FE Lotrich - Neuroscience, 2013 - Elsevier
Mounting evidence indicates that inflammatory cytokines contribute to the development of
depression in both medically ill and medically healthy individuals. Cytokines are important …
depression in both medically ill and medically healthy individuals. Cytokines are important …
Mindfulness practice leads to increases in regional brain gray matter density
BK Hölzel, J Carmody, M Vangel, C Congleton… - Psychiatry research …, 2011 - Elsevier
Therapeutic interventions that incorporate training in mindfulness meditation have become
increasingly popular, but to date, little is known about neural mechanisms associated with …
increasingly popular, but to date, little is known about neural mechanisms associated with …
Opponent interactions between serotonin and dopamine
Anatomical and pharmacological evidence suggests that the dorsal raphe serotonin system
and the ventral tegmental and substantia nigra dopamine system may act as mutual …
and the ventral tegmental and substantia nigra dopamine system may act as mutual …
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
M Vaswani, FK Linda, S Ramesh - Progress in neuro-psychopharmacology …, 2003 - Elsevier
The selective serotonin reuptake inhibitors (SSRIs) have emerged as a major therapeutic
advance in psychopharmacology. As a result, the discovery of these agents marks a …
advance in psychopharmacology. As a result, the discovery of these agents marks a …
Weight gain and antidepressants
M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …
who have weight loss as a symptom of depression or a residual symptom in patients who …
[HTML][HTML] Cardiometabolic effects of psychotropic medications
O Abosi, S Lopes, S Schmitz… - … molecular biology and …, 2018 - degruyter.com
Background Many psychiatric disorders including schizophrenia, bipolar disorder and major
depression convey an excess burden of cardiovascular morbidity and mortality. The …
depression convey an excess burden of cardiovascular morbidity and mortality. The …
Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects
Although neurotrophins have been postulated to have antidepressant properties, their effect
on anxiety is not clear. We find that transgenic overexpression of the neurotrophin BDNF has …
on anxiety is not clear. We find that transgenic overexpression of the neurotrophin BDNF has …
[HTML][HTML] Neural correlates of meditation: a review of structural and functional MRI studies
RF Afonso, I Kraft, MA Aratanha… - Frontiers in Bioscience …, 2020 - imrpress.com
Here, we review the neurophysiological and neuroimaging changes that mediation induces
in structural and functional MRI. The available evidence from structural studies suggests that …
in structural and functional MRI. The available evidence from structural studies suggests that …
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder
SH Kennedy, R Emsley - European Neuropsychopharmacology, 2006 - Elsevier
The efficacy and safety of flexible dosing with the antidepressant agomelatine (25–50
mg/day) was evaluated in a 6-week, double-blind, randomized, placebo-controlled study …
mg/day) was evaluated in a 6-week, double-blind, randomized, placebo-controlled study …